c-Raf Protein (RAF1)

c-Raf Protein (RAF1)

Overview

The RAF1 gene (also known as c-Raf or RAF1) encodes c-Raf kinase, the prototypical member of the Raf family of serine/threonine kinases that functions as the primary MAP kinase kinase kinase (MAP3K) in the RAS-RAF-MEK-ERK signaling cascade[@raf2020]. This three-tiered kinase cascade represents one of the most critical signaling pathways in eukaryotic cells, regulating cell proliferation, differentiation, survival, and apoptosis. In the central nervous system, c-Raf plays essential roles in neuronal development, synaptic plasticity, learning and memory, and cellular responses to stress and injury.

The RAF family consists of three highly conserved members—ARAF, BRAF, and RAF1 (c-Raf)—each with distinct expression patterns and functional specializations. While BRAF possesses the highest basal kinase activity and is the primary activator of MEK in most cell types, c-Raf exhibits unique kinase-independent functions and demonstrates tissue-specific roles that are particularly important in neuronal survival and synaptic function[@map2021]. Mutations in RAF1 cause Noonan syndrome and LEOPARD syndrome, neurodevelopmental disorders that include cognitive impairment, highlighting the critical importance of proper c-Raf signaling in brain function.

This page provides comprehensive information about c-Raf protein structure, normal physiological functions in the nervous system, and its contributions to neurodegenerative disease pathogenesis, with particular emphasis on Alzheimer's disease (AD), Parkinson's disease (PD), and related disorders.

c-Raf Protein (RAF1)

Overview

The RAF1 gene (also known as c-Raf or RAF1) encodes c-Raf kinase, the prototypical member of the Raf family of serine/threonine kinases that functions as the primary MAP kinase kinase kinase (MAP3K) in the RAS-RAF-MEK-ERK signaling cascade[@raf2020]. This three-tiered kinase cascade represents one of the most critical signaling pathways in eukaryotic cells, regulating cell proliferation, differentiation, survival, and apoptosis. In the central nervous system, c-Raf plays essential roles in neuronal development, synaptic plasticity, learning and memory, and cellular responses to stress and injury.

The RAF family consists of three highly conserved members—ARAF, BRAF, and RAF1 (c-Raf)—each with distinct expression patterns and functional specializations. While BRAF possesses the highest basal kinase activity and is the primary activator of MEK in most cell types, c-Raf exhibits unique kinase-independent functions and demonstrates tissue-specific roles that are particularly important in neuronal survival and synaptic function[@map2021]. Mutations in RAF1 cause Noonan syndrome and LEOPARD syndrome, neurodevelopmental disorders that include cognitive impairment, highlighting the critical importance of proper c-Raf signaling in brain function.

This page provides comprehensive information about c-Raf protein structure, normal physiological functions in the nervous system, and its contributions to neurodegenerative disease pathogenesis, with particular emphasis on Alzheimer's disease (AD), Parkinson's disease (PD), and related disorders.

Molecular Characteristics

Gene and Protein Structure

The human RAF1 gene is located on chromosome 3p25.3 and encodes a 648-amino acid serine/threonine protein kinase with a molecular mass of approximately 72.9 kDa. The protein contains three conserved regions (CR1, CR2, and CR3) that define the Raf kinase family:

| Region | Residues | Function |
|--------|---------|----------|
| CR1 (RBD + CRD) | 51-189 | Ras-binding domain (RBD) and cysteine-rich domain (CRD) for membrane localization and Ras GTPase interaction |
| CR2 (S259) | 190-299 | Serine-rich regulatory region with binding sites for 14-3-3 proteins |
| CR3 (Kinase) | 300-648 | Catalytic protein kinase domain |

The kinase domain (CR3) adopts the typical bilobal architecture of protein kinases, with an N-terminal regulatory lobe (residues 300-380) and a C-terminal catalytic lobe (residues 400-648). The ATP-binding pocket lies in the cleft between these lobes, with the activation segment (residues 491-509) containing the key regulatory phosphorylation sites.

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">c-Raf Protein (RAF1)</th></tr>
<tr><td><strong>Protein Name</strong></td><td>c-Raf (RAF1 kinase)</td></tr>
<tr><td><strong>Gene Symbol</strong></td><td><a href="/genes/raf1">RAF1</a></td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/P04049">P04049</a></td></tr>
<tr><td><strong>PDB Structures</strong></td><td>4R3Y, 4R40, 3KUD, 1LNX</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>72.9 kDa</td></tr>
<tr><td><strong>Protein Length</strong></td><td>648 amino acids</td></tr>
<tr><td><strong>Subcellular Location</strong></td><td>Cytoplasm, plasma membrane, mitochondria</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Raf serine/threonine kinases (MAP3K)</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>3p25.3</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/anxiety" style="color:#ef9a9a">Anxiety</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/depression" style="color:#ef9a9a">Depression</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">141 edges</a></td>
</tr>
</table>
</div>

Isoforms and Variants

Multiple RAF1 isoforms arise through alternative splicing:

• isoform 1 (canonical, 648 aa): Full-length isoform with complete kinase domain
• isoform 2 (572 aa): Truncated variant missing C-terminal sequences
• isoform 3 (Variant with alternative exon 2): Expressed in brain tissue

• S29: Constitutive phosphorylation
• S289 (CR2): 14-3-3 binding site
• S338: Activation loop phosphorylation (required for activation)
• Y340/Y345: Tyrosine phosphorylation by Src family kinases
• S497: Autophosphorylation site
• T491: Critical regulatory phosphorylation

• S-prenylation at C-terminal cysteine (CAAX motif)
• Palmitoylation at cysteines 260, 290, and 347

Signal Transduction Pathways

RAS-RAF-MEK-ERK Cascade

The canonical RAS-RAF-MEK-ERK signaling cascade represents a fundamental mechanism for extracellular signal transduction to the nucleus:

This cascade is critically involved in:

• Neuronal survival: Activation of pro-survival pathways through ERK5 and Akt
• Synaptic plasticity: Regulation of long-term potentiation (LTP) and memory formation
• Cellular responses: Integration of signals from neurotrophins (NGF, BDNF, GDNF)

Cross-talk with Other Pathways

c-Raf interacts with numerous signaling pathways beyond the classical MAPK cascade:

Normal Physiological Functions

Neuronal Development

During CNS development, c-Raf plays essential roles in:

Synaptic Plasticity and Memory

c-Raf is a critical regulator of synaptic plasticity, the cellular basis of learning and memory[@synapse_raf2020]:

Long-term Potentiation (LTP):

• NGF and BDNF signaling through Trk receptors activates c-Raf
• c-Raf activation leads to MEK/ERK signaling
• ERK phosphorylates CREB, driving expression of synaptic proteins
• Required for consolidation of LTP and long-term memory

• c-Raf regulates AMPA receptor internalization
• Required for synaptic scaling and homeostatic plasticity

Neuroprotection

c-Raf provides neuroprotection against various insults[@neuroprotection_raf2017]:

Mitochondrial Function

c-Raf localizes to mitochondria and regulates:

• Mitochondrial dynamics and fission/fusion
• ATP production and cellular metabolism
• Apoptosis through interactions with Bcl-2 family proteins
• Mitophagy in coordination with PINK1/Parkin pathway

Role in Neurodegenerative Diseases

Alzheimer's Disease

c-Raf signaling isdysregulated in Alzheimer's disease through multiple mechanisms:

Amyloid-β (Aβ) Effects on c-Raf:

• Aβ oligomers activate Fyn kinase, leading to abnormal tyrosine phosphorylation of c-Raf
• Aβ induces aberrant c-Raf localization to dendrites
• Chronic c-Raf activation contributes to tau hyperphosphorylation
• Impaired c-Raf signaling disrupts synaptic plasticity

• MEK inhibitors (e.g., selumetinib, trametinib) show promise in AD models
• Modulating c-Raf activity to restore proper signaling
• Targeting downstream effectors (ERK, Creb) for memory enhancement

Parkinson's Disease

c-Raf plays complex roles in PD pathogenesis:

Alpha-Synuclein Connection:

• α-Synuclein aggregation affects c-Raf signaling
• Impaired neurotrophin signaling through c-Raf in PD
• c-Raf provides protection against 6-OHDA toxicity

• GDNF-mediated neuroprotection requires c-Raf activation
• c-Raf/MEK/ERK signaling is reduced in PD brain
• Restoring c-Raf signaling is a therapeutic target

• LRK2 (leucine-rich repeat kinase 2) mutations are common in familial PD
• LRRK2 can phosphorylate c-Raf at regulatory sites
• Pathogenic LRRK2 variants show altered c-Raf interaction

Other Neurodegenerative Disorders

c-Raf dysfunction contributes to:

• Mutant SOD1 affects c-Raf signaling
• c-Raf activation in glial cells contributes to neuroinflammation

• Mutant huntingtin impairs c-Raf nuclear signaling
• ERK pathway dysregulation contributes to neuronal death

• c-Raf in oligodendrocyte survival
• Demyelination when c-Raf signaling impaired

Therapeutic Targeting

RAF-Selective Inhibitors

Several strategies for targeting RAF kinases in neurodegeneration:

| Drug | Target | Stage | Application |
|------|--------|-------|-------------|
| Sorafenib | Pan-RAF | Research | Neuroprotection |
| Pexidartinib | CSF1R + RAF | Research | Microglial modulation |
| Selumetinib | MEK1/2 | Preclinical | AD therapy |
| Trametinib | MEK1/2 | Research | Memory enhancement |
| Dabrafenib | B-Raf (V600E) | Research | Neurological disease |

Mechanism-Based Approaches

Strategies for therapeutic modulation:

Research Directions

Current research areas include:

Animal Models

Key findings from animal studies:

• Raf1 conditional knockout mice: Embryonic lethal, neuronal death
• Neuron-specific Raf1 knockdown: Impaired LTP, memory deficits
• Constitutive Raf1 activation: Increased neuronal survival
• c-Raf transgenic mice: Protection against Aβ toxicity

See Also

Related signaling pathways and proteins:

• [MAPK Signaling Pathway](/mechanisms/mapk-signaling-pathway)
• [RAF1 Gene](/genes/raf1)
• [MEK1 Protein (MAP2K1)](/proteins/mek-protein)
• [BRAF Protein](/proteins/braf-protein)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [ERK1/2 Signaling](/mechanisms/erk-signaling)
• [Synaptic Plasticity](/mechanisms/synaptic-plasticity)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving c-Raf Protein (RAF1) discovered through SciDEX knowledge graph analysis: